Fundamentals of Hematology and Hemostasis

Fundamentals of Hematology and Hemostasis

Welcome to this comprehensive module on hematology and hemostasis. This course is designed for medical students and clinicians who want a solid grounding in the cellular and molecular mechanisms that govern blood formation, transport, and clotting. By the end of the lesson you will be able to explain key concepts such as stem‑cell markers, erythropoietin production, red‑cell indices, iron distribution, and the genetic basis of myeloproliferative disorders.

Learning Objectives

• Identify the primary function of CD34 on hematopoietic stem cells.
• Describe the organ responsible for the majority of erythropoietin synthesis in adults.
• Define the mean corpuscular volume (MCV) range that characterizes microcytic anemia.
• Quantify the proportion of total body iron that circulates in plasma.
• Recall the specific JAK2 exon mutation most frequently found in polycythemia vera.

1. CD34 and Hematopoietic Stem Cells

Key Point: CD34 is a transmembrane glycoprotein that serves as a homing receptor for hematopoietic stem and progenitor cells (HSPCs).

When HSPCs leave the bone‑marrow niche or are mobilized for transplantation, CD34 interacts with selectins and extracellular matrix components, guiding the cells back to the marrow microenvironment. This adhesion property is essential for:

• Maintaining stem‑cell quiescence.
• Facilitating engraftment after bone‑marrow transplantation.
• Regulating trafficking during inflammation.

Clinical relevance: CD34 is routinely used as a marker to isolate stem cells for autologous and allogeneic transplants. Understanding its function helps clinicians predict mobilization efficiency and potential graft‑failure risks.

2. Erythropoietin (EPO) Production in Adults

Erythropoietin is the principal hormone that stimulates red‑cell production. While the fetal liver is the main source during development, the kidney becomes the dominant organ in adulthood, accounting for roughly 80‑90% of circulating EPO.

Renal peritubular fibroblasts sense oxygen tension; hypoxia triggers hypoxia‑inducible factor (HIF) stabilization, which up‑regulates the EPO gene. This feedback loop ensures rapid adaptation to anemia or high‑altitude exposure.

Clinical tip: Chronic kidney disease often leads to anemia because of impaired EPO synthesis. Recombinant EPO therapy is a cornerstone of treatment in these patients.

3. Mean Corpuscular Volume (MCV) and Microcytic Anemia

The MCV measures the average size of red blood cells and is expressed in femtoliters (fL). A microcytic anemia is defined by an MCV less than 80 fL. Common causes include iron deficiency, thalassemia, and chronic disease.

Interpretation of MCV values:

• Microcytic: < 80 fL – suggests iron‑deficiency or hemoglobin synthesis disorders.
• Normocytic: 80‑100 fL – typical of acute blood loss or hemolysis.
• Macrocytic: > 100 fL – often due to vitamin B12 or folate deficiency, or marrow dysplasia.

Accurate MCV assessment guides further diagnostic work‑up, such as iron studies or hemoglobin electrophoresis.

4. Iron Distribution in the Body

Iron is a vital element for oxygen transport, DNA synthesis, and cellular metabolism. The total body iron pool is approximately 3–4 grams, but only a tiny fraction circulates in plasma bound to transferrin.

Only about 0.1 percent of total body iron is present in the circulating plasma. The vast majority resides in:

• Hemoglobin within red blood cells (≈ 65 %).
• Myoglobin in muscle tissue (≈ 10 %).
• Storage forms such as ferritin and hemosiderin in the liver, spleen, and bone marrow (≈ 25 %).

Understanding this distribution is crucial when interpreting laboratory tests like serum iron, total iron‑binding capacity (TIBC), and ferritin.

5. JAK2 Mutation in Polycythemia Vera

Polycythemia vera (PV) is a clonal myeloproliferative neoplasm characterized by excessive red‑cell mass. The hallmark genetic alteration is a somatic point mutation in the JAK2 gene, specifically in exon 16 (V617F).

This mutation leads to constitutive activation of the JAK‑STAT signaling pathway, driving uncontrolled proliferation of erythroid, myeloid, and megakaryocytic lineages.

Diagnostic relevance: Detecting the JAK2 V617F mutation via PCR or next‑generation sequencing is a key criterion in the WHO diagnostic framework for PV.

Summary and Key Take‑aways

• CD34 mediates adhesion and homing of hematopoietic stem cells to bone‑marrow niches.
• The kidney is the principal source of erythropoietin in adults.
• Microcytic anemia is defined by an MCV < 80 fL.
• Only 0.1 % of total body iron circulates in plasma; most iron is bound in hemoglobin.
• Polycythemia vera commonly harbors the JAK2 V617F mutation located in exon 16.

Frequently Asked Questions (FAQ)

By mastering these core concepts, you will be better equipped to interpret laboratory data, diagnose hematologic disorders, and apply targeted therapies in clinical practice.